iShares Nasdaq Biotechnology Index Fund is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. As of Mar 31 2015, the Fund's total assets were $9,494,443,846 and the Fund's investment portfolio was valued at $9,486,288,900. We show 107 historical shares outstanding datapoints in our coverage of IBB's shares outstanding history.
Understanding the changing numbers of IBB shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like IBB versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching IBB by allowing them to research IBB shares outstanding history
as well as any other stock in our coverage universe. |
Free IBB Email Alerts:
Video: Shares Outstanding Importance
